Cardiome Pharma Corp. (NASDAQ: CRME) announced today that it received a Notice of Compliance for BRINAVESS® (vernakalant hydrochloride, IV) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE